Expression pattern of alternatively spliced PECAM-1 isoforms in hematopoietic cells and platelets

被引:36
作者
Wang, YJ
Sheibani, N
机构
[1] Univ Wisconsin, Sch Med, Dept Ophthalmol & Visual Sci, Madison, WI 53792 USA
[2] Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53792 USA
关键词
CD31; alternative splicing; angiogenesis; adherens junctions; cell-cell interactions;
D O I
10.1002/jcb.10321
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PECAM-1 (CD31) is a cell adhesion molecule that is highly expressed in the endothelium. Hematopoietic cells including platelets, monocytes, neutrophils, and some T cells also express moderate levels of PECAM-1. PECAM-1 undergoes alternative splicing generating a number of isoforms in the endothelium. However, the expression of PECAM-1 isoforms in hematopoietic cells and platelets has not been determined. Here, we examined the expression pattern of PECAM-1 isoforms inhuman and rodent hematopoietic cells and platelets by RT-PCR and DNA sequencing analysis. Our results showed that multiple PECAM-1 isoforms are expressed in a cell-type and species-specific pattern. We identified seven human PECAM-1 isoforms, six murine PECAM-1 isoforms, and four rat PECAM-1 isoforms. The full-length PECAM-1 was the predominant isoform detected in human cells. The PECAM-1 isoforms that lack exon 14 and 15 (Delta1415) or Delta12,14&15 were the predominant isoform in rodent cells. In addition, we identified a novel PECAM-1 isoform, Delta13&14, inhuman hematopoietic cells. Thus, hematopoietic cells express multiple isoforms of PECAM-1 in a pattern similar to that observed in the endothelium of the same species. The regulated expression of these isoforms may be important during hematopoiesis and transendothelial migration.
引用
收藏
页码:424 / 438
页数:15
相关论文
共 51 条
[11]  
Duncan GS, 1999, J IMMUNOL, V162, P3022
[12]   Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity [J].
Famiglietti, J ;
Sun, J ;
DeLisser, HM ;
Albelda, SM .
JOURNAL OF CELL BIOLOGY, 1997, 138 (06) :1425-1435
[13]   CHANGES IN EXPRESSION OF THE CELL-ADHESION MOLECULE PECAM-1 (CD31) DURING DIFFERENTIATION OF HUMAN LEUKEMIC-CELL LINES [J].
GOLDBERGER, A ;
MIDDLETON, KA ;
NEWMAN, PJ .
TISSUE ANTIGENS, 1994, 44 (05) :285-293
[14]  
GOLDBERGER A, 1994, J BIOL CHEM, V269, P17183
[15]   Altered vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1-deficient mice [J].
Graesser, D ;
Solowiej, A ;
Bruckner, M ;
Osterweil, E ;
Juedes, A ;
Davis, S ;
Ruddle, NH ;
Engelhardt, B ;
Madri, JA .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (03) :383-392
[16]   The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation - Evidence for a mechanistic link between PECAM-1- and integrin-mediated cellular signaling [J].
Jackson, DE ;
Ward, CM ;
Wang, RG ;
Newman, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :6986-6993
[17]  
LASTRES P, 1994, J IMMUNOL, V153, P4206
[18]  
LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673
[19]   Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis [J].
Lindemann, S ;
Tolley, ND ;
Dixon, DA ;
McIntyre, TM ;
Prescott, SM ;
Zimmerman, GA ;
Weyrich, AS .
JOURNAL OF CELL BIOLOGY, 2001, 154 (03) :485-490
[20]  
MANDRIOTA SJ, 1996, U77697 NCBI GEN